Post-Pandemic Awareness

Post the Corona virus outbreak, people have been inexorably moving towards a greener and cleaner system of healthcare that focusses on core immunity and strength of the body.

HempCann Solutions, through its wellness brand Vedi, has seen a significant rise in people looking for medicines and supplements that can be a part of one’s daily health regimen, without the side-effects of pharma drugs. For instance, the demand for Ayurvedic products have grown from an annual 15-20% to an appreciable 50% in general. Some of Vedi’s highest selling natural medicines have been its immunity package and its vitality medicines, like Ashwagandha.

Cannabis medicines have seen a worldwide surge for a few years now. Various business analysts have made more than healthy projections. For instance, the US cannabis market is slated to see $30 billion sales in 2022. This upbeat movement will most likely reflect in the Indian market as well, with Europe well on its way towards total cannabis legalisation.

“If the sales of our cannabis leaves extract medicines like Cannapain and Cannaflam are anything to go by, we expect a far better 2022, despite it not being considered a mainstream medicine. The reason being the efficacy of the products and improved awareness among people.”

(A marketing initiative by Open Avenues)